The test that settles it
Ask a leadership team two questions. What proportion of enquiries or referrals became a booked first appointment last month? And who owns that number? In organisations where access is treated as administration, the first answer requires a data request and the second answer is a team rather than a person. In organisations where access is treated as a growth function, both answers arrive immediately.
That difference is not cultural nicety. It determines whether an organisation can see its own bottleneck. A service can simultaneously carry a waiting list, unfilled clinical sessions and a marketing budget being increased — and every one of those facts looks like evidence for a different decision, unless someone owns the pathway end to end.
Where demand actually leaks
Having built and scaled a patient access organisation of more than 150 people, the leakage points are remarkably consistent across private providers, behavioural health services and digital health businesses in both the UK and US. They are rarely dramatic. They are small process decisions, each defensible, that compound.
Response latency
The interval between an enquiry arriving and a human making meaningful contact is the single most predictive number I know of in access performance. Healthcare enquiries are often made at a moment of decision; a reply the following afternoon meets a different person than a reply within the hour.
One-attempt contact
Many services attempt contact once, log it, and move on. Structured multi-attempt follow-up across more than one channel, with the attempts owned rather than optional, routinely recovers enquiries that were already interested.
Front-loaded friction
Long intake forms, funding questions and clinical history requested before any human relationship exists all suppress conversion. Collect what is needed to book safely; collect the rest afterwards.
Triage as a queue
Where triage is a holding step rather than a decision step, patients wait for an assessment of whether they should wait. Triage should route and book, not merely categorise.
Slot rules that strand capacity
Rigid slot types, protected sessions that go unfilled, and booking horizons that prevent short-notice use leave real capacity unused while the waiting list grows. This is where 'we need more clinicians' is most often wrong.
Unmanaged non-attendance
Non-attendance is treated as weather. Confirmation design, reminder timing and cadence, waiting-list pull-forward and same-day backfill are all controllable, and cheap relative to clinical headcount.
Capacity is usually a matching problem
When a service reports being at capacity, the aggregate figure is often true and the operational reality often is not. Capacity exists in specific slots, with specific clinicians, for specific patient types, at specific times. Demand arrives with its own shape. Where booking rules do not allow the two shapes to meet — wrong slot type, wrong seniority, wrong horizon, wrong location — capacity is stranded rather than absent.
This is why I encourage leadership teams to establish available throughput under improved rules before approving recruitment or new sites. Adding clinicians to a mismatched booking model adds cost faster than it adds care.
What running access as a growth function looks like
Practically, four things change. First, a named senior owner is accountable for conversion, time to first appointment, attendance and utilisation — reviewed on the same cadence as sales or revenue. Second, the pathway is documented as performed and redesigned deliberately, with the CRM or EHR configured to make the correct next action the easiest one. Third, the access team is treated as a skilled function with training, scripts, escalation routes and quality assurance, not as coverage. Fourth, capacity planning and demand generation are planned in the same conversation, so growth spend is released against capacity that exists.
None of this requires new technology to begin. It requires the front door to be treated as a commercial asset with an owner.
Why this matters before expansion or a transaction
Access performance travels. A provider that converts well and utilises well has a model worth replicating in a new market; one that does not will export its leakage at higher cost. The same applies under diligence: access conversion and utilisation are among the first things I test when an investor asks whether a growth plan is deliverable, as set out in operational due diligence. For expansion, the front door decides whether US entry economics hold — US market entry covers that in more detail.
How Clarendum works on this directly is set out under patient access consulting.
Frequently asked questions
- What counts as patient access?
- Everything between a person or referrer making contact and that patient being seen and retained: enquiry handling, referral triage, eligibility checks, scheduling, reminders, cancellation and rebooking, and the capacity model those steps draw on.
- Why is patient access a growth issue rather than an operations issue?
- Because it sits directly on the revenue line. Demand that arrives and does not convert has already been paid for through marketing, referral relationships or reputation. Improving conversion of existing demand is usually cheaper per additional patient than generating more of it.
- Where should a provider start?
- Measure enquiry-to-first-appointment conversion and time to first appointment, then walk ten real enquiries through the pathway end to end. The gap between the process as designed and the process as performed is where the first improvements always are.
Want to know where your front door leaks?
A short call is usually enough to identify the two or three access changes with the largest effect on booked, attended care.